von user zoomlik auf yahoo:
Hold to your shares
See presentation posted in the sec filing .. 1- elxobitat is blockbuster .. Great p2 data ..,Japan nda q1 2017,.. Different mechanism than sgyp and ironwood linzines large bowl vs small intestine 2- the orphan is open lable and read out 2h 2016 .. Most likely good and before closing 3- most important. Is no mention of b531, 123 and 961 and lawsuit ... My guess they were valued zero in deal .. They are probably close to final sale and settlement and any cash we should get dividend before closing
Ich bin gespannt, ob er mit der pipeline von Biodel recht behält.
|